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Background: South Asian migrants are at particularly high risk of type 2 diabetes. Previous studies have shown that
intensive lifestyle interventions may prevent the onset of diabetes. Such interventions have not been culturally
adapted and evaluated among South Asians in industrialized countries. Therefore, we have set up a randomized
controlled trial to study the effectiveness of a targeted lifestyle intervention for the risk of type 2 diabetes and
cardiovascular risk factors among 18 to 60-year-old Hindustani Surinamese (South Asians) in The Hague, the
Netherlands. Here we present the study design and describe the characteristics of those recruited.
Methods: Between May 18, 2009 and October 11, 2010, we screened 2307 Hindustani Surinamese (18–60 years old)
living in The Hague. We sent invitations to participate to those who had an impaired fasting glucose of 5.6-
6.9 mmol/l, an impaired glucose tolerance of 7.8-11.0 mmol/L, a glycated hemoglobin level of 6.0% or more and/or
a value of 2.39 or more for the homeostasis model assessment of estimated insulin resistance. In total, 536 people
(56.1% of those eligible) participated. People with a higher level of education and a family history of type 2
diabetes were more likely to participate. The control and intervention groups were similar with regard to important
background characteristics. The intervention group will receive a culturally targeted intervention consisting of
dietary counseling using motivational interviewing and a supervised physical activity program. The control group
will receive generic lifestyle advice. To determine the effectiveness, a physical examination (anthropometrics,
cardiorespiratory test, lipid profile, and measures of oral glucose tolerance, glycated hemoglobin, and insulin) and
interview (physical activity, diet, quality of life, and intermediate outcomes) were carried out at baseline and will be
repeated at 1 year and 2 years. The process and the costs will be evaluated.
Discussion: This trial will provide insight into the feasibility and effectiveness of a targeted, intensive, lifestyle
intervention for the risk of type 2 diabetes and cardiovascular risk factors among 18 to 60-year-old South Asians.
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Type 2 diabetes mellitus (DM) is one of the most com-
mon chronic diseases in the industrialized countries [1].
The burden of DM is expected to increase due to factors
such as aging, urbanization, and the increasing preva-
lence of obesity and physical inactivity [1].
South Asian migrants and their offspring living in
industrialized countries (henceforth “South Asians”) are
at particularly high risk of DM [1–4]. In the Netherlands
for example, the prevalence among the Hindustani Suri-
namese, who are of South Asian origin, is about four
times as great as that among the ethnic Dutch in the
same age group [4]. South Asians are not only younger
at presentation, they are also at high risk of developing
complications [3–6]. Hence, prevention of new DM
cases and DM-related morbidity among South Asians
potentially leads to an important health gain [7].
Previous studies have shown that intensive lifestyle
interventions prevent the onset of DM among older
populations with pre-diabetes [8–10]. Yet, while it seems
particularly relevant, such intensive lifestyle interven-
tions have not been implemented among South Asians
in industrialized countries. There are two reasons. First,
information about the feasibility and effectiveness of
such interventions is lacking. This is particularly import-
ant, as South Asians are less likely to participate in inter-
vention programs than their European counterparts
[7,11,12]. Second, these interventions have not culturally
targeted South Asians, while cultural adaptations likely
have great influence on the effectiveness of interventions
among specific populations [13,14].Figure 1 Design of the DH!AAN study. Legend: aFPG of 100–125 mg/dl
(7.8–11.0 mmol/l), bHOMA-IR≥ 2.39. ADA, American Diabetes Association; F
glucose tolerance; HbA1c, glycated hemoglobin; HOMA-IR, homeostasis mo
randomized controlled trial.Therefore, we want to study the effectiveness of a tar-
geted, intensive, lifestyle intervention concerning the risk
of DM and cardiovascular risk factors among 18 to
60-year-old Hindustani Surinamese (South Asians) in
The Hague, the Netherlands. We will also evaluate
the process and costs of the intervention to deter-
mine whether the targeted intervention program was
feasible and implemented as planned. This paper a)
outlines the protocol for the recruitment and a 2-year
randomized controlled trial (RCT) and b) describes
an analysis of the participation in the RCT and the
baseline characteristics of the participants.
Methods/design
In this paper, we describe the protocol of the RCT. The
original protocol was adjusted during the study period
because the recruitment period was extended, but the
end date of the study was fixed. The changes in the ori-
ginal protocol are described in the Online Supplement
(Additional file 1).
Study design
This study was set up as an RCT with one intervention
group and one control group (Figure 1). We invited po-
tential participants for a screening to determine their
risk of DM. If DM was suspected, the person concerned
was referred to the family physician for further diagnos-
tic testing and treatment. Those who appeared to be at
“high risk of DM” were invited to participate in the
RCT. We used a computer-generated randomization list
to randomly assign invitees who gave their informed(5.6–6.9 mmol/l) and/or 2-h postload glucose of 140–199 mg/dl
PG, fasting plasma glucose; IFG, impaired fasting glucose; IGT, impaired
del assessment of estimated insulin resistance; M, measurements; RCT,
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trol group. Family members (n= 38), that is, participants
belonging to the same household, defined as having the
same postal code and house number, were assigned to
the same program.
The main goal was to compare the risk of DM and
several cardiovascular risk factors in the intervention
group and the control group over time. The primary
outcomes are changes in weight, mean blood glucose
concentration, and behavioral change [diet and physical
activity (PA)]. The secondary outcomes are cardiovascu-
lar risk factors, the use of primary health care and inter-
mediate behavioral outcomes. Therefore, measurements
were carried out at baseline and will be repeated after 1
and 2 years. The Medical Ethics Committee of the Aca-
demic Medical Center of Amsterdam, The Netherlands,
has approved the study.
Recruitment of the study population
Study population and invitation procedure
The study population consisted of Hindustani Surinam-
ese persons. The term “Hindustani Surinamese” refers to
people of South Asian ancestral origin and their off-
spring who migrated to the Netherlands via Suriname.
The Hindustani Surinamese are the descendants of the
labourers from North India - Uttar Pradesh, Uttaranchal,
and West Bihar – who were indentured between 1873
and 1917. The two large migration waves of Hindustani
Surinamese to the Netherlands were caused mainly by
the political situation in Suriname. The first wave took
place at the time of the independence of Suriname in
1975, and the second wave, at the time of Desi
Bouterse’s coup in February 1980 [15].
We selected 10,583 Hindustani Surinamese (South
Asians), aged 18–60 years, from 48 family physician lists
in The Hague by means of name analysis. We chose the
age range of 18 to 60 years because of the high preva-
lence of DM among 35 to 44-year-old South Asians in
the Netherlands [4]. The researcher, the family physician
or the practice nurse, and a trained research assistant of
Hindustani Surinamese origin verified the names. We
excluded people known to have DM and pregnant
women (Figure 2). We chose to recruit via the family
physician because of evidence that ethnic minority
groups in the Netherlands in general appear to have
confidence in their family physician ([16,17] and unpub-
lished data). Moreover, we assumed that working
through health care providers would facilitate future
implementation.
The family physicians sent each potential participant
an invitation letter with a reply card that could be
returned if further contact was unwanted. Family mem-
bers and other volunteers (n= 163) could also make an
appointment for the screening. We culturally tailoredthe invitation by using the colors of the Surinamese flag
and a Hindustani eye in the logo of the study, by citing a
key figure encouraging participation, and by using the
study name ‘DH!AAN’ – an acronym that means “atten-
tion” in Sarnami Hindustani, the Surinamese variant of
Hindi. Moreover, we used plain language in the letter
and leaflet, and we adjusted the risk information about
DM to the Hindustani Surinamese population.
We sent a written reminder to invitees who had not
responded to the invitation within 2 weeks and invited
them to make an appointment. The reminder also said
that if no response was received (no appointment or
reply card) within 1 week, the invitee would be con-
tacted by telephone. The study team phoned those who
had not responded on at least three occasions (attempts
varying in the afternoon and in the evening). If no tele-
phone number was available (as was the case for 24.1%
of the potential participants) or potential participants
could not be reached, we sent a second written
reminder asking people to contact us. This intensive
recruitment strategy was tested during the pilot study
and proved to be feasible and to achieve a higher re-
sponse rate than only written invitations and reminders
(unpublished data).
Initial screening
The initial screening took place between May 18, 2009
and November 11, 2010. All participants (n = 2307) in
the screening were asked to donate a fasting blood sam-
ple. We asked them to answer a brief questionnaire,
which asked about their self-identified ethnicity (includ-
ing the country of birth of the participants and of their
parents), education level, their own DM status and that
of first- and second-degree relatives, and previous med-
ical diagnoses. Trained research staff carried out physical
examinations in a standardized protocol in which they
measured weight, height, and blood pressure (Table 1).
All measurements were obtained twice.
The participants who were invited and screened be-
tween May 18, 2009 and April 18, 2010 (n= 968) took
an oral glucose tolerance test (OGTT; 75 g). The phys-
ical examination for these participants also included
measurements of body fat and waist and hip circumfer-
ence. Moreover, four blood samples were collected for
storage (Table 1).
Inclusion and exclusion criteria
If the person’s fasting glucose was impaired [a fasting
plasma glucose (FPG) level of 5.6-6.9 mmol/l], glucose
tolerance was impaired (2-h postload of 7.8-11.0 mmol/
l), the hemoglobin (Hb)A1c was 6.0% or more, and/or the
value for the homeostasis model assessment of estimated
insulin resistance (HOMA-IR) was 2.39 or more [18–21],
then the person was considered “at high risk of DM” and
INCLUSION INITIAL SCREENING 
TRIAL INCLUSION 
Assessed for eligibility initial screening (n=10,583) 
(10,418 selected via family physicians’ registers and 165 volunteers) 
Excluded (n=8276): 
• Not meeting inclusion criteria (n=1658) 
• Declined to participate (n=1804) 
• Other reasons (n=49) 
• No shows (n=298) 
• Not reached (n=4467) 
Screened (n=2307)
Participation within age groups: 18–34 years, 14.2%; 35–44 years, 23.3%; 45–60 years, 31.1% 
Participation within gender groups: 18.5% men, 24.8% women 
At high risk of diabetes and assessed for eligibility RCT (n=1045)
Excluded (n=403): 
• Not meeting inclusion criteria (n=67) 
• Actively declined (n=158) 
• Other reasons (n=16) 
• Not reached (n=162) 
Randomized (n=642)
In intervention group (n=283) In control group (n=253)
Excluded: 
• With normoglycemia* (n=1197) 
• Had DM** (n=65) 
Allocated to control group (n=310)
• Completed baseline measurements  (n=253)
• No show (n=49) 
• Had DM during baseline measurement RCT 
(n=8) 
Allocated to intervention group (n=332) 
• Completed baseline measurements (n=283) 
• No show (n=35) 
• Had DM during baseline measurement RCT 
(n=14) 
Figure 2 Flow diagram from eligibility assessment to inclusion in the trial. Legend: *Including n = 129 classified as normoglycemia during
initial screening due to original protocol and n= 7 classified as normoglycemia during the baseline measurement and prior to randomization due
to original protocol (Additional file 1); **Including n= 2 classified as DM during the baseline measurement and prior to randomization due to
original protocol (Additional file 1); “High risk of DM” refers to having a fasting plasma glucose of 100–125 mg/dl (5.6 – 6.9 mmol/l) and/or 2-h
postload glucose of 140–199 mg/dl (7.8–11.0 mmol/l); DM, type 2 diabetes mellitus; RCT, randomized controlled trial.
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based on the median value for HOMA-IR of the first 349
participants in the screening and is comparable to the
median among people with DM of 2.4, as Matthews et al.
(1985) find ([21] and unpublished data).
We asked potential participants for their consent (oral
and written) and excluded anyone who was already
involved in a lifestyle program, was pregnant, had a
chronic disease that made participation in theintervention impossible, and/or used drugs interfering
with plasma glucose levels. We evaluated this condition
on a case-by-case basis.
Response and participation
Participation in the initial screening Of all those who
received an invitation, 2307 (21.8%) participated in the
screening (Figure 2): 18.5% of the men and 24.8% of the
Table 1 Measurements among participants in the RCT












SC HV SC HV
I. Laboratory assessments
1.Fasting plasma glucose, HbA1c, insulin Fasting venous blood sample x x x d x d
2.2-h Postload glucose 2-h postload glucose b x x x
3.Triglycerides, HDL, LDL, cholesterol, creatinine, hs-CRP Fasting venous blood sample x x x
4.Albumin and creatinine (urine) Fasting urine sample x x x x x x
5.Blood sample storage (serum, EDTA) Fasting venous blood sample b c x
II.Anthropometry
6.Weight, height, blood pressure (Omron M5-1) SOP: twice, blood pressure
measured 5 times
x x x x x x
7. Waist and hip circumferences, fat percentage
(Omron 500)
SOP: twice b x x x
III. Behavior
8.PA (SQUASH [22] adapted to SA [23]) Questionnaire (interview) x x x x x
9.Diet (based on guideline for healthful diet) Questionnaire (interview) x x x x x x
10.Smoking [24] Questionnaire (interview) x x x x x x
11.Alcohol [25] Questionnaire (interview) x x x x x x
IV. Other measurementsa
12.Ethnicity, household information Questionnaire x
13.Education, income, insurance, religion [26] Questionnaire (interview) education x x x x x
14.Physical health (cardiovascular risk profile; [27]) Questionnaire (interview) f g g g g g
15.Cardio respiratory test (Chester STEP test; [28,29]) SOP x x x
16.Perceived quality of life (SF-15; [30,31]) Questionnaire (interview) x x x x x
17.Distress (part of 4DSQ; [32]) Questionnaire (interview) x x x x x
18.Risk perception ([33] and our own questionnaire) Questionnaire (interview) x x x x x x
19.Attitude, knowledge, social support, self-efficacy,
and stages of change in PA and diet
Questionnaire (interview) x x x x x
20.Perception of one’s own body Questionnaire (interview) x x x x x
V. Process
21.Dose received (participation in intervention
components, frequency, leaflet, satisfaction)
Questionnaire (interview) x
VI. Costs
1.Use of health care Questionnaire (interview) x x x x x
2.Costs of screening and lifestyle intervention Questionnaire (interview) h x x x x x
Legend: aQuestionnaire developed for the study; b – participants until April 19th, 2010 (n = 968); c – participants since April 19th, 2010; d – only HbA1c
measurement; f – heart disease, hypertension, high cholesterol, artritis and diabetes; g – heart failure and stroke; h – only costs screening; SC, screening; HV, home
visit; SOP, standard operating procedures; PA,physical activity; HDL, high-density lipoprotein; hs-CRP, highly sensitive C-reactive protein; LDL, low-density
lipoprotein; PA, physical activity; SA, South Asian(s); SQUASH, Short Questionnaire to Assess Health-Enhancing Physical Activity; 4DSQ, Four-Dimensional Symptom
questionnaire.
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aged 45–60 years (31.1%) than among those aged 18–
34 years (14.2%) or 35–44 years (23.3%). The net partici-
pation rate was 25.8% (2307 of those eligible (n = 8925)).Participation in the randomized controlled trial In
total, 536 people (283 intervention group; 253 control
group) were included in the RCT (Figure 2). Of all the
people considered at high risk of DM (n= 1045), 158
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people (8.5%) were found not eligible; 67 prior to the
randomization and 22 during the baseline measurement
because of suspected DM. The net participation rate in
the trial was 56.1% (536 of those eligible (n = 956)).
The characteristics of the participants, as measured in
the initial screening, were comparable with the character-
istics of the nonparticipants, with the exception of family
history of DM and education (Table 2). Participants more
often reported having a family member with DM than
nonparticipants (chi-squared test, p= 0.043). Moreover,
the participants had a somewhat higher level of education
than the nonparticipants (Mann–Whitney U test,
p= 0.023). Nonparticipants seemed to have a higher blood
pressure and were more likely to be classed as having ele-
vated fasting glucose, but this was not significant.
Baseline characteristics of the participants
The median age of the participants was 45 years [inter-
quartile range (IQR): 37–52] and 265 participants
(49.4%) were men (Table 3). Most participants had an
intermediate education level and had relatives in the first
or second degree with DM. The median body mass
index (BMI) was 26.9 kg/m2 (IQR: 24.6–29.7), and the
mean waist circumference was 95.0 cm (SD: 10.9) for
men and 90.7 cm (SD: 10.5) for women. Moreover, the
mean FPG level was 5.3 mmol/l (SD: 0.5), the median 2-
h postload plasma glucose level was 5.8 mmol/l (IQR:
4.8–6.9) and the median HbA1c level was 5.7% (IQR:
5.4–5.9). No significant differences were found between
the intervention group and the control group (Table 3).
Intervention group: The design of the lifestyle
intervention
The aim of the lifestyle intervention is to meet the
current guidelines for diet and PA [34,35]. We used data
from previous qualitative and quantitative research
within the Department of Public Health to adjust the
intervention design, which was based on the design of
the intervention in the SLIM study, to the situation in
The Hague and the Hindustani Surinamese population
[36–38].
The intervention consists of culturally targeted lifestyle
counseling and a supervised PA program (exercise on
prescription). Trained dieticians will conduct the lifestyle
counseling, which consists of individual sessions and an
optional program comprising a family session and cook-
ing classes. The combination of diet and PA is often used
in intensive lifestyle programs and appears to be more ef-
fective in preventing DM than diet or PA alone [8,9,39].
To target the diabetes prevention program to the Hindu-
stani Surinamese population, we have added both surface
and deep structure adaptations to make the intervention
attractive, appropriate, and ultimately more effective[14]. The colors and key figures in the leaflet are exam-
ples of using the superficial characteristics of a cultural
group; they can be seen as surface-structure adaptations
[14]. Deep structure adaptations are adaptations targeted
to factors that influence health behavior [14]. Paying spe-
cific attention to social pressure and support is an ex-
ample of a deep structure adaptation in this study.
Individual lifestyle counseling
The individual lifestyle counseling consists of six to eight
sessions in the 1st 6 months, followed by 3 to 4 booster
sessions in the next 1.5 years, and it aims at both diet
and PA. We use motivational interviewing (MI) as a
counseling strategy, taking into account dietary habits
and cultural norms regarding diet and PA. Motivational
interviewing can be defined as “a client-centered, direct-
ive method for enhancing intrinsic motivation to change
by exploring and resolving ambivalence” [40]. Motiv-
ational interviewing is an upcoming intervention meth-
odology, and the evidence for MI for lifestyle advice
seems to be promising [41,42].
The six dieticians who will conduct the lifestyle coun-
seling are familiar with the Hindustani Surinamese cul-
ture and dietary habits. The medical psychologist who
trained the dieticians in MI is an expert in MI [43]. Spe-
cial attention will be paid to possible barriers and stimu-
lating factors that are specific to the Hindustani
Surinamese population. As recommended, we will pro-
vide continued support for MI to achieve optimal results
in appliance and effects [44].
Family session and cooking classes
Besides the individual sessions, participants will also be
offered a family session with the dietician. The purpose
of this session is to decrease the social pressure to eat
unhealthily and to increase the social support for a
healthful lifestyle for the family. This entails providing
product information and discussing the importance of a
healthful lifestyle and how to increase support.
The participants will be offered two cooking classes to
increase their self-efficacy in skills that they can learn
for adjusting traditional dishes in a more healthful way.
They will be encouraged to bring spouses or close rela-
tives with them to increase their knowledge and attitude
towards healthful diet.
Exercise on prescription
The intervention group will be offered “exercise on pre-
scription” (EoP), a 20-week supervised PA program,
which has previously been described [45–47]. The parti-
cipants can choose between aquarobics and fitness,
offered in men-only or women-only groups [45,46].
Trained PA coaches will monitor and supervise the par-
ticipation. At the end of the 20 weeks, a final evaluation
Table 2 Determinants of participation for those eligible for the trial
All eligible people Participants Nonparticipants Significance*
n=956^ n=536 n=420
Median age in years 44 (36–51) 45 (37–52) 44 (35–51) 0.13
Men (%) 468 (49.0) 265 (49.4) 203 (48.3) 0.73
18–34 years (%) 212 (22.2) 109 (20.3) 103 (24.5)
35–44 years (%) 280 (29.3) 159 (29.7) 121 (28.8)
45–60 years (%) 464 (48.5) 268 (50.0) 196 (46.7)
Education (%) 0.02**
Elementarya 126 (13.6) 61 (11.7) 65 (16.1)
Intermediateb 645 (69.8) 364 (70.0) 281 (69.6)
University or equivalentc 153 (16.6) 95 (18.3) 58 (14.4)
Relatives with DM (%)d 685 (73.7) 398 (76.2) 287 (70.3) 0.04**
Median weight in kg 73.5 (64.8–82.0) 73.3 (65.0–82.1) 73.8 (64.0–82.1) 0.90
Median BMI in kg/m2 26.8 (24.4–29.9) 26.8 (24.5–29.7) 26.7 (24.1–30.3) 0.98
Overweight: ≥ 23 kg/m2 (%)e 419 (44.9) 246 (46.9) 173 (42.3) 0.17
Obesity: ≥ 27.5 kg/m2 (%)e 412 (44.1) 227 (43.2) 185 (45.2) 0.54
Median SBP in mm Hg 128.0 (119.0–38.0) 127.0 (118.0–137.0) 129.0 (120.0–0.0) 0.07
Median DBP in mm Hg 83.0 (76.0–90.0) 82.0 (76.0–90.0) 84.0 (76.0–92.0) 0.06
Hypertension (%)f| 62 (38.4) 196 (37.1) 166 (40.1) 0.34
Median FPG (mmol/l) 5.3 (4.9–5.7) 5.3 (4.9–5.7) 5.4 (5.0–5.7) 0.61
Elevated FPG†(%) 332 (34.8) 174 (32.5) 158 (37.9) 0.08
Median HbA1c in percentage 5.7 (5.4–6.0) 5.7 (5.4–6.0) 5.7 (5.4–5.9) 0.36
Elevated HbA1c: ≥ 6.0% (%) 238 (25.1) 138 (25.8) 100 (24.2) 0.57
Median HOMA in mmol/mol 3.2 (2.6–4.4) 3.2 (2.5–4.3) 3.3 (2.7–4.4) 0.36
HOMA-IR: ≥ 2.39 (%) 800 (84.0) 453 (84.5) 347 (83.4) 0.65
Determinants measured during initial screening only; only determinants measured in total population are shown Data are n (percentages, calculated excluding
missings), means (SD) if normally distributed or medians (IQRs) if not normally distributed ^All people labeled as ‘at high risk of diabetes’ (n= 1045) minus people
who were found not eligible for the trial (n= 67 prior to randomization and n= 22 because of suspected DM during baseline measurement) *p calculated with
chi-squared test (binary data), independent t-test (continuous data), and Mann–Whitney U test (ordinal/nominal data and not normal distributed data).
**p< 0.05 – chi-squared test (Relatives with DM)/Mann–Whitney U test (Education).
aPrimary education or less.
bLow vocational training, lower secondary education, intermediate vocational training and higher secondary education.
cHigher vocational training or university.
dFirst and second grade.
eBMI of 23–27.5 kg/m2 was considered overweight; a BMI of 27.5 kg/m2 or more, obesity [48].
fSBP ≥140 mm Hg and/or of DBP≥ 90 mm Hg or if hypertension medication.
gAmerican Diabetes Association definition: fasting glucose value of 100–125 mg/dl (5.6–6.9 mmol/l).
BMI, body mass index; DBP, diastolic blood pressure; DM, type 2 diabetes mellitus; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HOMA-IR, homeostasis
model assessment of estimated insulin resistance; IQR, interquartile range; SBP, systolic blood pressure.
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provide information about low-budget sport locations.
Control group
The participants in the control group will be invited to
join two group sessions led by student dieticians (after
baseline measurements and after 6 months). The student
dieticians will provide generic information about dia-
betes, discuss the current guidelines for diet and PA, list
methods for achieving the recommended PA, and
present some cases. In the second session, one respond-
ent will be given the opportunity to become a case study.In addition, the control group will receive two flyers (at
3 months and 9 months) with simple, generic lifestyle
advice. Both flyers offer participants a chance to phone
in during preset hours to obtain personal advice from a
dietician.
Data collection
For both the intervention group and the control group,
the baseline (T0) and subsequent measurements after 1
(T1) and 2 years (T2) of the trial include blood sampling
[fasting and 2-hour OGTT (glucose load 75 g)], a struc-
tured face-to-face interview, and a physical examination.
Table 3 Baseline characteristics of the participants
Participants Intervention group Control group Significance*
n=536 n=283 n=253
Median age in years 45 (37–52) 45 (37–52) 44 (37–51) 0.49
Men (%) 265 (49.4) 136 (48.1) 129 (51.0) 0.50
Education (%) 0.36
Elementarya 61 (11.7) 27 (9.9) 34 (13.7)
Intermediateb 364 (70.0) 192 (70.6) 172 (69.4)
University or equivalentc 95 (18.3) 53 (19.5) 42 (16.9)
Family with DM (%)d 398 (76.2) 214 (77.8) 184 (74.5) 0.37
Median BMI in kg/m2 26.9 (24.5–29.6) 26.9 (24.7–29.5) 27.0 (24.4–29.8) 0.90
Mean waist circumference in cm
Men 95.0 (10.9) 95.0 (10.5) 95.0 (11.4) 0.99
Women 90.7 (10.5) 90.4 (10.6) 91.1 (10.4) 0.60
Median SBP in mm Hg 125.5 (117.0–37.3) 125.7 (117.5–7.5) 125.0 (116.5–36.5) 0.53
Mean DBP in mm Hg 83.0 (10.0) 83.3 (9.9) 82.7 (10.2) 0.51
Hypertension (%)e| 200 (38.6) 105 (38.3) 95 (38.9) 0.89
Plasma glucose in mmol/l
Mean FPG 5.3 (0.5) 5.3 (0.6) 5.3 (0.5) 0.77
Median 2-h postload glucose 5.8 (4.8–6.9) 5.9 (5.0–7.0) 5.5 (4.8–6.9) 0.12
Median HbA1c in % 5.7 (5.4–5.9) 5.7 (5.4–5.9) 5.6 (5.4–5.9) 0.31
Median HOMA-IR 3.1 (2.2–4.1) 3.1 (2.2–4.2) 3.0 (2.3–4.1) 0.91
Median insulin in pmol/l 12.9 (9.6–17.3) 13.4 (9.6–17.5) 12.8 (9.6–17.1) 0.86
Mean LDL in mmol/l 3.2 (0.9) 3.2 (0.8) 3.2 (0.9) 0.83
Median HDL in mmol/l) 1.2 (1.0–1.4) 1.2 (1.1–1.4) 1.2 (1.0–1.4) 0.27
Data are given as n (percentages, calculated excluding missings), means (SD) if normally distributed or medians (IQRs) if not normally distributed.
*p is given as calculated with the chi-squared test (binary data), independent t-test (continuous data), or Mann–Whitney U test (ordinal/nominal data and not
normally distributed data).
aPrimary education or less.
bLow vocational training, lower secondary education, intermediate vocational training and higher secondary education.
cHigher vocational training and university.
dFirst and second grade.
eSystolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure≥ 90 mm Hg or if hypertension medication.
BMI, body mass index; DBP, diastolic blood pressure; DM, type 2 diabetes mellitus; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL, high-density
lipoprotein; HOMA-IR, homeostasis model assessment of estimated insulin resistance; IQR, interquartile range; LDL, low-density lipoprotein; SBP, systolic blood
pressure; SD, standard deviation.
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one central health care center in The Hague. The parti-
cipants will receive a questionnaire after 6 months as
part of the process evaluation. Participants who do not
fill in the questionnaire at 6 months will be asked to
complete it at T1 in the health care center. Table 1
shows the measures recorded at baseline and to be
recorded again after 6 months, 1 year, and 2 years. Parti-
cipants who were not reached and any participants who
indicate that they intend to quit the trial at T1 or T2 will
be offered a brief home visit instead of the more exten-
sive screening at the health care center (Table 1).Laboratory assessments
Plasma glucose, insulin, and HbA1c levels and other bio-
markers will be assessed (Table 1). All laboratoryassessments will be carried out according a standardized
protocol at the General Practice Laboratory Foundation,
Etten-Leur, The Netherlands. At different time points,
material is stored at −80°C for future analyses (Table 1).Physical examination
Trained research staff carries out the physical examina-
tions in a standardized protocol. A Seca mechanical
scale (Seca 761, Seca, Hamburg, Germany) is used to
weigh the participants (wearing light clothing) to the
nearest 500 g. Height is recorded to the nearest 0.01 m
on a Seca portable stadiometer (Seca 214, Seca, Hamburg,
Germany), and waist and hip circumferences are deter-
mined to the nearest 0.01 m with a tape measure. A bio-
electrical impedance analysis (OMRON BF500, Omron
Healthcare, Hoofddorp, The Netherlands) is used to
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ric measurements are obtained twice – we allowed differ-
ences between two measurements of 2 cm, 2 kg, or 2% –
and the means will be used for analysis.
The participant is in the seated position when the
blood pressure (Omron M5-1, Omron Healthcare,
Hoofddorp, The Netherlands) is measured on the non-
dominant arm supported at heart level. At most, five
measurements are taken. We calculate the mean from
the first two measurements with less than 5 mm Hg dif-
ference in both systolic and diastolic blood pressure
[49]. We assess cardiorespiratory fitness with the
Chester STEP test [28,29].
Structured face-to-face interview
Behavioral outcomes We will assess PA with the Short
Questionnaire to Assess Health-enhancing Physical Ac-
tivity (SQUASH), supplemented with ethnicity-specific
activities [22,23]. Dietary intake will be determined with
questions based on the national guideline for a healthful
diet, supplemented with questions about specific dietary
habits of the Hindustani Surinamese population [34,38].
We will assess fruit, vegetables, rice, and bread con-
sumption with multi-item measurements to determine
the quantity and frequency (n= 3, n= 2, n= 2, and n= 11,
respectively), and two single-item questions will address
the use of breakfast and the regularity of the meals. We
will also measure the current smoking and alcohol con-
sumption (Table 1) [24,25].
Intermediate outcome measures Health-related qual-
ity of life will be measured with short form (SF)-12
and three extra emotional status questions from SF-
36 [30,31]. We will measure distress with the 16 dis-
tress questions of the Four-Dimensional Symptom
Questionnaire (distress, depression, anxiety, and
somatization) [32].
We will measure personal vulnerability with a three-
item personal vulnerability score [33] and risk percep-
tion with 12 statements about the participant’s perceived
risk of diabetes in connection with overweight, current
smoking, and/or unhealthy eating. The statements are
based on general risk factors and information from focus
group discussions [37,50].
We will determine attitudes towards PA and diet dir-
ectly with questions about importance and joy regarding
several aspects of PA and diet (e.g., PA in leisure time;
breakfast; fruit, vegetable and whole grain intake). We
will assess attitude towards PA indirectly with seven
items about the possible consequences of increasing PA
(e.g., “If I increase my PA, I will look better”).
We will ask whether the spouse, other family mem-
bers, or close relatives encourage the respondent to bephysically active (n= 3). Moreover, we will measure over-
all support towards the targeted aspects of diet (n= 7).
We will measure self-efficacy expectations towards
diet change and dealing with specific PA barriers with
five items about PA and seven items about aspects of
diet [focus group discussions; unpublished data].
The stage of change towards PA and diet will be mea-
sured with the algorithm described in the Transtheoretical
Model [51]. This includes three scales regarding motiv-
ation to change, described as: unmotivated to change diet
and PA within 6 months, motivated to change at least
parts of the diet and PA within 6 months, and prepared to
change within 1 month [52].
Background characteristics We will assess physical
health, religion, and socioeconomic status (as indicated
by educational level, source of income, and net family
income) using questions similar to those of the SUNSET
study [26,27].
Activities to encourage participation in the data
collection
We will send all participants the DH!AAN study news-
letter twice a year in order to inform them of the pro-
gress of the study and to encourage continued
participation. The participants were rewarded with a gift
coupon of €5 to €10 for their participation in the base-
line measurements; this reward will be repeated for sub-
sequent measurements. Moreover, a prize in the form of
a trip to Suriname will be raffled to one of the partici-
pants of the T1 and T2 measurements.
Statistical analysis
Size of the study population and the power calculation
The Online supplement (Additional file 1) describes the
original power calculation. Here we calculate the power
of the study to demonstrate differences in the main out-
comes using the numbers of participants in the interven-
tion and control groups.
A total of 536 participants were included in the RCT
with a minimum of 253 participants per group. Previous
studies found a difference in weight reduction of 1.5–
3 kg (SD of 4) [10,53], and a difference in FPG of 0.2–
0.35 mmol/l (SD of 0.7) [10,53]. Assuming a an alpha of
5%, and a dropout rate of 30%, we have a power of 86%
or more to demonstrate a minimum difference in weight
reduction of 1.25 kg and a change in glucose level of
0.2 mmol/l with our data.
Effectiveness of the intensive lifestyle intervention
Statistical analysis will be performed according to the
intention-to-treat principle and, if necessary, corrected
for differences in background characteristics between
the intervention and control groups. To assess the effect
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cardiovascular risk factors after 1 and 2 years, we will
calculate differences between the intervention and con-
trol groups in general linear mixed models (GLMM). If
we observe a difference between the intervention and
control groups, we will examine whether the magnitude
of the effect is most likely due to other cardiovascular
risk factors or behavioral change. We will also use
GLMM to examine the influence of baseline variables
and the degree of participation (e.g., adherence and the
actual carrying out of the components of the interven-
tion) in weight reduction and behavioral changes. We
will use multilevel analyses to distinguish group effects
(e.g., effect of dietician’s work) from individual effects.
Process evaluation
In the process evaluation we will investigate for each
intervention component fidelity, dose received (exposure
and satisfaction) and dose delivered [54]. Several mea-
sures will be used including a structured questionnaire
at six months, semi-structured interviews with a sample
of participants and non-participans, dieticians’ files and
audiotapes of the counseling sessions of participants
with dieticians.
We will measure fidelity with questions in the ques-
tionnaire and semi-structured interview about relevance,
understandability, and satisfaction with each component
of both lifestyle interventions. We will determine the
level of MI applied from the audiotapes using One Pass,
which is based on the Motivational Interviewing Skill
Code scoring list [55]. We will assess the level of cultural
sensitivity during the MI sessions with a scoring list spe-
cially designed for this study. We based it on a combin-
ation of the Seeleman and colleagues’ cultural sensitivity
model and diverse existing scoring lists for cultural
sensitivity [56–58].
We will measure measure the dose received (exposure)
and the dose delivered by asking participants about their
participation in each component of the intervention and
analysing the dieticians’ registration files.
Evaluation of the costs
We developed questions in collaboration with a health
economist to determine the costs. We asked participants
to note their travel time, mode of transportation, travel
costs, and hours of work missed for the screening in the
recruitment phase and at T0, but will only ask about any
change in transportation at T1 and T2 (Table 1). We will
measure costs for the intervention program in the ques-
tionnaire at 6 months; for example, the time invested,
the cost of the change of diet, and the cost of participat-
ing in an exercise program (e.g., sportswear; Table 1).
Moreover, to measure whether the screening and
intervention affected the use of primary health care,we will ask participants about their use of certain
health care, laboratory assessments, and medication at
T0, T1, and T2 (Table 1).
Discussion
Our study is unique in terms of population (South
Asians in industrialized countries), age (young popula-
tion), the mode of recruitment, and the culturally tar-
geted design of the intervention. No studies have
reported on the feasibility and potential effectiveness of
an intensive lifestyle intervention in this population,
while South Asians in industrialized countries are at
high risk of DM and are therefore an important target
group. Given this high risk of DM, we used broad cri-
teria for inclusion. For instance, in contrast with previ-
ous studies, we did not restrict participation to those
with overweight. We selected participants on the basis
of high levels of HbA1c and HOMA-IR as these mar-
kers have been independently associated with diabetes
risk [19,20,59,60]. Using HbA1c as a marker for DM
and people at high risk of DM is in line with recent
recommendations [19,61].
This strategy is illustrative for the design of our trial,
which incorporates both pragmatic and explanatory ele-
ments according to the definitions of Roland and Toger-
son [62]. Because of this, we expect to be able to provide
information how and why the intervention works, but
also insight in whether this intervention may work in
real life conditions.
Despite the lack of specific evidence, results from earl-
ier studies suggest that DM screening and intervention
among South Asians – with a culturally sensitive ap-
proach – may be effective and lead to a decrease in the
burden of DM and risk of cardiovascular disease
[7,13,63,64]. For instance, one study in India has
reported an effect of a lifestyle intervention on the inci-
dence of DM. However, given the substantial differences
in context, their results are not generalizable to South
Asians living in industrialized countries [64].
Limitations
Our study has some limitations that should be men-
tioned. First, participation in the initial screening and at
baseline was relatively low, despite our intensive and tar-
geted recruitment strategy. The participation rate is
often low in studies among ethnic minority groups in
western countries [7,12,65,66]. Our initial screening had
a higher participation rate than another study that was
partially targeted to this population [7].
The low participation may be associated with selection
bias. We cannot rule this out in our study. As in previous
studies, participation in the initial screening was highest
among women and older people [8,67,68]. Moreover,
participation at baseline was greater among people with a
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having family with diabetes than among those who did
not. This may be related to the fact that well-educated
people or people who have a family history of DM are
more motivated to engage in preventive behavior [66–69].
At the same time, other background characteristics of the
participants and nonparticipants were comparable. Never-
theless, we should keep in mind that selection bias may
affect the generalizability of our findings.
Another limitation of the study is that, during its
course, we were forced to shorten the duration of the
follow-up to 2 years, instead of maintaining the origin-
ally intended 3 years. As a consequence, the focus on
the incidence of type 2 diabetes shifted to other outcome
measures. We acknowledge that this limits the assess-
ment of the effectiveness for the prevention of incident
DM. However, we believe that our findings will still pro-
vide valuable insight into feasibility and will indicate the
potential health gain that can be achieved.
Changes in several relevant outcomes, e.g., diet and
physical activity, will be assessed by means of question-
naires. However, self-reported behavior may be subject
to recall bias and social desirability [70]. This can be
partly overcome if we combine these self-reported data
with an assessment of more objective measures intended
to provide insight into the effectiveness [71].
In summary, this study will contribute to the evidence
base for lifestyle interventions for the prevention of DM.
Specifically, the trial will provide insight into the poten-
tial effectiveness of a targeted intensive lifestyle interven-
tion among 18 to 60-year-old South Asians in an
industrialized country who form a population at high risk
of DM. During the 2-year study we will assess the
changes in a broad range of relevant outcomes. More-
over, we expect that the evaluation of the process and
costs will provide important information about the feasi-
bility of a culturally targeted lifestyle intervention among
South Asians via general practices and other health care
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